Kings College Hospital London, London, United Kingdom.
Ethics Unit, Institute of Humanities in Medicine, University Hospital of Lausanne, London, United Kingdom.
Transpl Int. 2022 Mar 18;35:10084. doi: 10.3389/ti.2022.10084. eCollection 2022.
Inequitable access to deceased donor organs for transplantation has received considerable scrutiny in recent years. Emerging evidence suggests patients with impaired decision-making capacity (IDC) face inequitable access to transplantation. The "Ethical and Legal Issues" working group of the European Society of Transplantation undertook an expert consensus process. Literature relating to transplantation in patients with IDC was examined and collated to investigate whether IDC is associated with inferior transplant outcomes and the legitimacy of this healthcare inequality was examined. Even though the available evidence of inferior transplant outcomes in these patients is limited, the working group concluded that access to transplantation in patients with IDC may be inequitable. Consequently, we argue that IDC should not in and of itself be considered as a barrier to either registration on the transplant waiting list or allocation of an organ. Strategies for non-discrimination should focus on ensuring eligibility is based upon sound evidence and outcomes without reference to non-medical criteria. Recommendations to support policy makers and healthcare providers to reduce unintended inequity and inadvertent discrimination are set out. We call upon transplant centres and national bodies to include data on decision-making capacity in routine reporting schedules in order to improve the evidence base upon which organ policy decisions are made going forward.
近年来,对移植用已故供体器官的公平获取问题进行了大量审查。新出现的证据表明,决策能力受损的患者(IDC)在获取移植方面面临不公平待遇。欧洲移植学会的“伦理和法律问题”工作组进行了一项专家共识过程。检查并整理了与 IDC 患者移植相关的文献,以调查 IDC 是否与较差的移植结果有关,并审查这种医疗保健不平等的合法性。尽管这些患者的移植结果较差的证据有限,但工作组得出结论,IDC 患者的移植机会可能不公平。因此,我们认为,IDC 本身不应该被视为在移植等待名单上登记或分配器官的障碍。非歧视策略应侧重于确保资格是基于可靠的证据和结果,而不是基于非医疗标准。提出了支持政策制定者和医疗保健提供者的建议,以减少意外的不公平和无意识的歧视。我们呼吁移植中心和国家机构将决策能力数据纳入常规报告计划,以改善器官政策决策的依据。